Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Ponti

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Familial Cancer|May 9, 2012
Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndromeGiovanni Ponti, Lorenza Pastorino, Annamaria Pollio, et al.
Disease Markers|March 5, 2014
Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanomasGiovanni Ponti, Ponti Giovanni, Giovanni Pellacani, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|April 27, 2011
Quantitative evaluation of healthy epidermis by means of multiphoton microscopy and fluorescence lifetime imaging microscopyElisa Benati, Valerio Bellini, Stefania Borsari, et al.
International Journal of Dermatology|June 16, 2011
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma SyndromeGiovanni Ponti, Gabriele Luppi, Lorena Losi, et al.
Melanoma Research|January 30, 2013
Can noninvasive imaging tools potentially predict the risk of ulceration in invasive melanomas showing blue and black colors?Caterina Longo, Francesca Farnetani, Elvira Moscarella, et al.
Journal of Clinical Pathology|March 7, 2013
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutationsGiovanni Ponti, Giovanni Pellacani, Aldo Tomasi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 14, 2019
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosisGiovanni Ponti, Monia Maccaferri, Marco Manfredini, et al.
Plos One|September 7, 2012
Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndromeLorenza Pastorino, Annamaria Pollio, Giovanni Pellacani, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 30, 2008
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA)Giovanni Ponti, Lorena Losi, Giovanni Pellacani, et al.
The Journal of Investigative Dermatology|February 3, 2007
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigreesGiovanni Ponti, Tiziana Venesio, Lorena Losi, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Familial Cancer|May 9, 2012
Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndromeGiovanni Ponti, Lorenza Pastorino, Annamaria Pollio, et al.
Disease Markers|March 5, 2014
Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanomasGiovanni Ponti, Ponti Giovanni, Giovanni Pellacani, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|April 27, 2011
Quantitative evaluation of healthy epidermis by means of multiphoton microscopy and fluorescence lifetime imaging microscopyElisa Benati, Valerio Bellini, Stefania Borsari, et al.
International Journal of Dermatology|June 16, 2011
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma SyndromeGiovanni Ponti, Gabriele Luppi, Lorena Losi, et al.
Melanoma Research|January 30, 2013
Can noninvasive imaging tools potentially predict the risk of ulceration in invasive melanomas showing blue and black colors?Caterina Longo, Francesca Farnetani, Elvira Moscarella, et al.
Journal of Clinical Pathology|March 7, 2013
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutationsGiovanni Ponti, Giovanni Pellacani, Aldo Tomasi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 14, 2019
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosisGiovanni Ponti, Monia Maccaferri, Marco Manfredini, et al.
Plos One|September 7, 2012
Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndromeLorenza Pastorino, Annamaria Pollio, Giovanni Pellacani, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 30, 2008
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA)Giovanni Ponti, Lorena Losi, Giovanni Pellacani, et al.
The Journal of Investigative Dermatology|February 3, 2007
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigreesGiovanni Ponti, Tiziana Venesio, Lorena Losi, et al.
Pageof 10